Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01907191 · ClinicalTrials.gov registry record · NA
Ultrasound Guided Local Infiltration Analgesia for Hip Arthroscopy
A NA study, sponsored by Trinity Health Of New England.
- Terminated
- Registry status
- NA
- Development phase
- 23
- Enrollment target
NCT01907191: Clinical Trial NA study, sponsored by Trinity Health Of New England.
NCT01907191 is a NA study that was terminated before completion, run by Trinity Health Of New England. The registered enrollment target is 23 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01907191, a NA study, was terminated before completion, sponsored by Trinity Health Of New England.
- TERMINATED
- Registry status
- NA
- Development phase
- 23 participants
- Enrollment target
Study Summary
This study is being undertaken to compare the pain control using either bupivacaine versus liposomal bupivacaine. Liposomal bupivacaine can potentially provide pain relief lasting up to 72 hours while regular bupivacaine can provide pain relief up to 12 hours
Primary Outcome
Consumption of 5mg Oxycontin tablets will be assessed on Post Operative Days 1, 2 \& 3.
Interventions
- DRUG Bupivacaine
- DRUG liposomal bupivacaine
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 23 participants |
| Start Date | 2013-07 |
| Est. Completion | 2019-01-30 |
| Phase | NA |
Why NCT01907191 stopped before completion
NCT01907191 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 23 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower).
The record links to 0 conditions, and to 2 interventions - of which Bupivacaine is the first listed.
NCT01907191 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01907191 about?
NCT01907191 is a clinical study titled "Ultrasound Guided Local Infiltration Analgesia for Hip Arthroscopy". This study is being undertaken to compare the pain control using either bupivacaine versus liposomal bupivacaine. Liposomal bupivacaine can potentially provide pain relief lasting up to 72 hours while regular bupivacaine can provide pain relief up to 12 hours
What is the current status of trial NCT01907191?
This trial is currently terminated. It is a NA study. The enrollment target is 23 participants. The study started on 2013-07. Estimated completion is 2019-01-30.
What interventions are being tested in trial NCT01907191?
The interventions under investigation include: Bupivacaine (DRUG), liposomal bupivacaine (DRUG).
Who is sponsoring clinical trial NCT01907191?
This trial is sponsored by Trinity Health Of New England, which has 20 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT01907191's enrollment target sits among peer trials
23 1755th of 2000 higher than 245 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03616041 · 23 participants
Capsule Endoscopy for Severe Hematochezia
- NCT04348747 · 23 participants · Phase 2
Dendritic Cell Vaccines Against Her2/Her3 and Pembrolizumab for the Treatment of Brain Metastasis From Triple Negative Breast Cancer or HER2+ Breast Cancer
- NCT04587687 · 23 participants · Phase 2
Brentuximab Vedotin and Bendamustine for the Treatment of Relapsed or Refractory Follicular Lymphoma
- NCT04715022 · 23 participants · Phase 1
Sympathetic-vascular Dysfunction in Obesity and Insulin Resistance (Vitamin C Study)
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia